Tissue Regenix Revenue vs. EBITDA
| TRX Stock | 58.50 0.00 0.00% |
For Tissue Regenix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Tissue Regenix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Tissue Regenix Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Tissue Regenix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Tissue Regenix Group over time as well as its relative position and ranking within its peers.
Tissue |
Tissue Regenix Group EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Tissue Regenix's current stock value. Our valuation model uses many indicators to compare Tissue Regenix value to that of its competitors to determine the firm's financial worth. Tissue Regenix Group is currently regarded number one company in revenue category among its peers. It also is currently regarded as top stock in ebitda category among its peers totaling about 0.02 of EBITDA per Revenue. The ratio of Revenue to EBITDA for Tissue Regenix Group is roughly 66.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tissue Regenix's earnings, one of the primary drivers of an investment's value.Tissue Revenue vs. Competition
Tissue Regenix Group is currently regarded number one company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 2.27 Trillion. Tissue Regenix adds roughly 29.49 Million in revenue claiming only tiny portion of equities under Health Care industry.
Tissue EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Tissue Regenix |
| = | 29.49 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Tissue Regenix |
| = | 446 K |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Tissue EBITDA Comparison
Tissue Regenix is currently under evaluation in ebitda category among its peers.
Tissue Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Tissue Regenix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Tissue Regenix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Tissue Regenix's important profitability drivers and their relationship over time.
Use Tissue Regenix in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tissue Regenix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will appreciate offsetting losses from the drop in the long position's value.Tissue Regenix Pair Trading
Tissue Regenix Group Pair Trading Analysis
The ability to find closely correlated positions to Tissue Regenix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tissue Regenix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tissue Regenix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tissue Regenix Group to buy it.
The correlation of Tissue Regenix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tissue Regenix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tissue Regenix Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tissue Regenix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Tissue Regenix position
In addition to having Tissue Regenix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Tissue Stock
To fully project Tissue Regenix's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Tissue Regenix Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Tissue Regenix's income statement, its balance sheet, and the statement of cash flows.